Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Brazil Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20051
20062
20072
20082
20101
20121
20131
20141
20161
20171
20182
20191
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated5
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi5
Boehringer Ingelheim3
Bayer2
Bristol-Myers Squibb2
University of Sao Paulo General Hospital2
Anthos Therapeutics, Inc.1
AstraZeneca1
Biosense Webster, Inc.1
CSL Behring1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation25
Stroke8
Arrhythmias, Cardiac3
Cardiovascular Diseases2
Embolism2
Heart Diseases2
Hemorrhage2
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Flutter1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.